Nucleic acid-sensing TLRs: trafficking and regulation

Current Opinion in Immunology

Volumn 44, Issue , 2017, Pages 26-33

  Majer, Olivia ^a   Liu, Bo ^a   Barton, Gregory M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; LIGAND;

ADAPTIVE IMMUNITY; BINDING AFFINITY; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; DNA FRAGMENTATION; HOMEOSTASIS; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; AGONISTS; ANIMAL; AUTOIMMUNITY; CYTOPLASM VESICLE; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; METABOLISM;

ANIMALS; AUTOIMMUNITY; CYTOPLASMIC VESICLES; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIGANDS; NUCLEIC ACIDS; PROTEIN TRANSPORT; PROTEOLYSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84998611004     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.10.003     Document Type: Review

References (64)

1. 1 Janeway, C.A. Jr., Approaching the asymptote?. Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54:Pt 1 (1989), 1–13.
2. 2 Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11 (2010), 373–384.
3. 3 Oldenburg, M., Kruger, A., Ferstl, R., Kaufmann, A., Nees, G., Sigmund, A., Bathke, B., Lauterbach, H., Suter, M., Dreher, S., et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 337 (2012), 1111–1115.
4. 4 Schlee, M., Hartmann, G., Discriminating self from non-self in nucleic acid sensing. Nat Rev Immunol 16 (2016), 566–580.
5. 5 Barton, G.M., Kagan, J.C., Medzhitov, R., Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7 (2006), 49–56.
6. 6 Ewald, S.E., Lee, B.L., Lau, L., Wickliffe, K.E., Shi, G.P., Chapman, H.A., Barton, G.M., The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456 (2008), 658–662.
7. 7 Ishii, N., Funami, K., Tatematsu, M., Seya, T., Matsumoto, M., Endosomal localization of TLR8 confers distinctive proteolytic processing on human myeloid cells. J Immunol 193 (2014), 5118–5128.
8. 8 Pisitkun, P., Deane, J.A., Difilippantonio, M.J., Tarasenko, T., Satterthwaite, A.B., Bolland, S., Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312 (2006), 1669–1672.
9. 9 Deane, J.A., Pisitkun, P., Barrett, R.S., Feigenbaum, L., Town, T., Ward, J.M., Flavell, R.A., Bolland, S., Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27 (2007), 801–810.
10. 10• Newman, Z.R., Young, J.M., Ingolia, N.T., Barton, G.M., Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9. Proc Natl Acad Sci U S A 113 (2016), E1362–E1371 Suboptimal codon bias of the Tlr7 gene locus, which correlates with low GC content, limits TLR7 expression relative to TLR9. Poor codon usage results in decreased gene transcription and translation and represents a new mechanism to establish low levels of TLR7, whose overexpression is known to cause autoimmunity.
11. 11 Miyake, K., Shibata, T., Ohto, U., Shimizu, T., Emerging roles of the processing of nucleic acids and Toll-like receptors in innate immune responses to nucleic acids. J Leukoc Biol, 2016 Epub ahead of print (jlb.4MR0316-108R).
12. 12 Yang, Y., Liu, B., Dai, J., Srivastava, P.K., Zammit, D.J., Lefrancois, L., Li, Z., Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26 (2007), 215–226.
13. 13 Takahashi, K., Shibata, T., Akashi-Takamura, S., Kiyokawa, T., Wakabayashi, Y., Tanimura, N., Kobayashi, T., Matsumoto, F., Fukui, R., Kouro, T., et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204 (2007), 2963–2976.
14. 14 Liu, B., Yang, Y., Qiu, Z., Staron, M., Hong, F., Li, Y., Wu, S., Li, Y., Hao, B., Bona, R., et al. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nat Commun, 1, 2010, 79.
15. 15 Kim, Y.M., Brinkmann, M.M., Paquet, M.E., Ploegh, H.L., UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452 (2008), 234–238.
16. 16 Lee, B.L., Moon, J.E., Shu, J.H., Yuan, L., Newman, Z.R., Schekman, R., Barton, G.M., UNC93B1 mediates differential trafficking of endosomal TLRs. Elife, 2, 2013, e00291.
17. 17 Brinkmann, M.M., Spooner, E., Hoebe, K., Beutler, B., Ploegh, H.L., Kim, Y.M., The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 177 (2007), 265–275.
18. 18 Casrouge, A., Zhang, S.Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., Alcais, A., Picard, C., Mahfoufi, N., Nicolas, N., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314 (2006), 308–312.
19. 19 Tatematsu, M., Funami, K., Ishii, N., Seya, T., Obuse, C., Matsumoto, M., LRRC59 regulates trafficking of nucleic acid-sensing TLRs from the endoplasmic reticulum via association with UNC93B1. J Immunol 195 (2015), 4933–4942.
20. 20 Fukui, R., Saitoh, S., Matsumoto, F., Kozuka-Hata, H., Oyama, M., Tabeta, K., Beutler, B., Miyake, K., Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA — but against RNA-sensing. J Exp Med 206 (2009), 1339–1350.
21. 21 Fukui, R., Saitoh, S., Kanno, A., Onji, M., Shibata, T., Ito, A., Onji, M., Matsumoto, M., Akira, S., Yoshida, N., et al. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity 35 (2011), 69–81.
22. 22 Christensen, S.R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R.A., Shlomchik, M.J., Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 (2006), 417–428.
23. 23 Nickerson, K.M., Christensen, S.R., Shupe, J., Kashgarian, M., Kim, D., Elkon, K., Shlomchik, M.J., TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 184 (2010), 1840–1848.
24. 24 Chiang, C.Y., Engel, A., Opaluch, A.M., Ramos, I., Maestre, A.M., Secundino, I., De Jesus, P.D., Nguyen, Q.T., Welch, G., Bonamy, G.M., et al. Cofactors required for TLR7- and TLR9-dependent innate immune responses. Cell Host Microbe 11 (2012), 306–318.
25. 25 Sasai, M., Linehan, M.M., Iwasaki, A., Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329 (2010), 1530–1534.
26. 26 Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., Taniguchi, T., Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005), 1035–1040.
27. 27 Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K.A., Monks, B.G., Knetter, C.F., Lien, E., Nilsen, N.J., Espevik, T., Golenbock, D.T., TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5 (2004), 190–198.
28. 28 Wu, J.Y., Kuo, C.C., ADP-ribosylation factor 3 mediates cytidine-phosphate-guanosine oligodeoxynucleotide-induced responses by regulating toll-like receptor 9 trafficking. J Innate Immun 7 (2015), 623–636.
29. 29 Chockalingam, A., Rose, W.A. 2nd, Hasan, M., Ju, C.H., Leifer, C.A., Cutting edge: a TLR9 cytoplasmic tyrosine motif is selectively required for proinflammatory cytokine production. J Immunol 188 (2012), 527–530.
30. 30 Hasan, M., Gruber, E., Cameron, J., Leifer, C.A., TLR9 stability and signaling are regulated by phosphorylation and cell stress. J Leukoc Biol 100 (2016), 525–533.
31. 31 Tsai, S.Y., Segovia, J.A., Chang, T.H., Shil, N.K., Pokharel, S.M., Kannan, T.R., Baseman, J.B., Defrene, J., Page, N., Cesaro, A., et al. Regulation of TLR3 activation by S100A9. J Immunol 195 (2015), 4426–4437.
32. 32 Ewald, S.E., Engel, A., Lee, J., Wang, M., Bogyo, M., Barton, G.M., Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 208 (2011), 643–651.
33. 33 Garcia-Cattaneo, A., Gobert, F.X., Muller, M., Toscano, F., Flores, M., Lescure, A., Del Nery, E., Benaroch, P., Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci U S A 109 (2012), 9053–9058.
34. 34 Qi, R., Singh, D., Kao, C.C., Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization. J Biol Chem 287 (2012), 32617–32629.
35. 35 Sepulveda, F.E., Maschalidi, S., Colisson, R., Heslop, L., Ghirelli, C., Sakka, E., Lennon-Dumenil, A.M., Amigorena, S., Cabanie, L., Manoury, B., Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31 (2009), 737–748.
36. 36 Hipp, M.M., Shepherd, D., Gileadi, U., Aichinger, M.C., Kessler, B.M., Edelmann, M.J., Essalmani, R., Seidah, N.G., Reis e Sousa, C., Cerundolo, V., Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes. Immunity 39 (2013), 711–721.
37. 37 Onji, M., Kanno, A., Saitoh, S., Fukui, R., Motoi, Y., Shibata, T., Matsumoto, F., Lamichhane, A., Sato, S., Kiyono, H., et al. An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing. Nat Commun, 4, 2013, 1949.
38. 38 Sinha, S.S., Cameron, J., Brooks, J.C., Leifer, C.A., Complex negative regulation of TLR9 by multiple proteolytic cleavage events. J Immunol 197 (2016), 1343–1352.
39. 39 Kanno, A., Yamamoto, C., Onji, M., Fukui, R., Saitoh, S., Motoi, Y., Shibata, T., Matsumoto, F., Muta, T., Miyake, K., Essential role for Toll-like receptor 7 (TLR7)-unique cysteines in an intramolecular disulfide bond, proteolytic cleavage and RNA sensing. Int Immunol 25 (2013), 413–422.
40. 40 Toscano, F., Estornes, Y., Virard, F., Garcia-Cattaneo, A., Pierrot, A., Vanbervliet, B., Bonnin, M., Ciancanelli, M.J., Zhang, S.Y., Funami, K., et al. Cleaved/associated TLR3 represents the primary form of the signaling receptor. J Immunol 190 (2013), 764–773.
41. 41•• Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., Miyake, K., Shimizu, T., Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature 520 (2015), 702–705 This structural study establishes the molecular basis by which immunostimulatory CpG-oligonucleotides elicit TLR9 responses. Three distinct crystal structures of TLR9: unbound, bound to agonist DNA, and bound to inhibitory DNA reveal the difference between these ligands in binding TLR9 and inducing receptor dimerization.
42. 42 Tanji, H., Ohto, U., Shibata, T., Miyake, K., Shimizu, T., Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 339 (2013), 1426–1429.
43. 43•• Zhang, Z., Ohto, U., Shibata, T., Krayukhina, E., Taoka, M., Yamauchi, Y., Tanji, H., Isobe, T., Uchiyama, S., Miyake, K., et al. Structural analysis reveals that Toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity 45 (2016), 737–748 This study is the first one to introduce the natural ligands for TLR7. TLR7 harbors two distinct ligand binding sites: one for a single guanosine and the second one for a short ssRNA oligoribonucleotide. Both of these sites have to be bound to trigger receptor activation. In contrast, an artificial small-molecule agonist is able to activate TLR7 by binding the first site only. This new concept of TLR7 recognizing break-down products of nucleic acids suggests the existence of specific RNases involved in the processing of lysosomal RNA.
44. 44 Liu, L., Botos, I., Wang, Y., Leonard, J.N., Shiloach, J., Segal, D.M., Davies, D.R., Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320 (2008), 379–381.
45. 45 Ewald, S.E., Barton, G.M., Nucleic acid sensing Toll-like receptors in autoimmunity. Curr Opin Immunol 23 (2011), 3–9.
46. 46• Tanji, H., Ohto, U., Motoi, Y., Shibata, T., Miyake, K., Shimizu, T., Autoinhibition and relief mechanism by the proteolytic processing of Toll-like receptor 8. Proc Natl Acad Sci U S A 113 (2016), 3012–3017 Proteolytic cleavage of the TLR8 ectodomain is a prerequisite for receptor dimerization and activation. Using a TLR8 mutant with a non-cleavable ectodomain, the authors show that the uncleaved Z-loop sterically interferes with the dimerization process.
47. 47 Tanji, H., Ohto, U., Shibata, T., Taoka, M., Yamauchi, Y., Isobe, T., Miyake, K., Shimizu, T., Toll-like receptor 8 senses degradation products of single-stranded RNA. Nat Struct Mol Biol 22 (2015), 109–115.
48. 48 Choe, J., Kelker, M.S., Wilson, I.A., Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309 (2005), 581–585.
49. 49 Latz, E., Verma, A., Visintin, A., Gong, M., Sirois, C.M., Klein, D.C., Monks, B.G., McKnight, C.J., Lamphier, M.S., Duprex, W.P., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8 (2007), 772–779.
50. 50 Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H.L., et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 34 (2004), 251–262.
51. 51 Geyer, M., Pelka, K., Latz, E., Synergistic activation of Toll-like receptor 8 by two RNA degradation products. Nat Struct Mol Biol 22 (2015), 99–101.
52. 52 Lee, C.C., Avalos, A.M., Ploegh, H.L., Accessory molecules for Toll-like receptors and their function. Nat Rev Immunol 12 (2012), 168–179.
53. −/− mice, this work establishes the requirement of lysosomal DNase II for TLR9 activation. CpG-A, which contains a DNase II-sensitive sequence motif, as well as genomic bacterial DNA need to be processed by DNase II to generate shorter DNA fragments able to stimulate TLR9.
54. 54 Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H.G., Moroy, T., Features of systemic lupus erythematosus in DNase1-deficient mice. Nat Genet 25 (2000), 177–181.
55. 55 Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., Kuroda, Y., Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28 (2001), 313–314.
56. 56 Al-Mayouf, S.M., Sunker, A., Abdwani, R., Abrawi, S.A., Almurshedi, F., Alhashmi, N., Al Sonbul, A., Sewairi, W., Qari, A., Abdallah, E., et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 43 (2011), 1186–1188.
57. 57 Mizuta, R., Araki, S., Furukawa, M., Furukawa, Y., Ebara, S., Shiokawa, D., Hayashi, K., Tanuma, S., Kitamura, D., DNase gamma is the effector endonuclease for internucleosomal DNA fragmentation in necrosis. PLoS One, 8, 2013, e80223.
58. 58 Wilber, A., Lu, M., Schneider, M.C., Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection. Mol Ther 6 (2002), 35–42.
59. 59•• Sisirak, V., Sally, B., D'Agati, V., Martinez-Ortiz, W., Ozcakar, Z.B., David, J., Rashidfarrokhi, A., Yeste, A., Panea, C., Chida, A.S., et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell 166 (2016), 88–101 DNASE1L3 is required for the degradation of extracellular microparticle-associated chromatin released by apoptotic cells. These microparticles, when not continuously cleared, can serve as potential self-antigens able to activate NA-sensing TLRs and trigger autoimmune responses.
60. 60 Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H., Nagata, S., Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol 6 (2005), 49–56.
61. 61 Ahn, J., Gutman, D., Saijo, S., Barber, G.N., STING manifests self DNA-dependent inflammatory disease. Proc Natl Acad Sci U S A 109 (2012), 19386–19391.
62. 62 Baum, R., Sharma, S., Carpenter, S., Li, Q.Z., Busto, P., Fitzgerald, K.A., Marshak-Rothstein, A., Gravallese, E.M., Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis and autoantibody production in DNase II-deficient mice. J Immunol 194 (2015), 873–877.
63. 63 Shibata, T., Ohto, U., Nomura, S., Kibata, K., Motoi, Y., Zhang, Y., Murakami, Y., Fukui, R., Ishimoto, T., Sano, S., et al. Guanosine and its modified derivatives are endogenous ligands for TLR7. Int Immunol 28 (2016), 211–222.
64. 64 Pawaria, S., Moody, K., Busto, P., Nundel, K., Choi, C.H., Ghayur, T., Marshak-Rothstein, A., Cutting edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands. J Immunol 194 (2015), 1403–1407.